Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 336,888 | 186,374 | 77,062 | 19,138 | 0 |
| Cost of Goods | 81,643 | 47,039 | 12,374 | 1,903 | N/A |
| Gross Profit | 255,245 | 139,335 | 64,688 | 17,235 | N/A |
| Operating Expenses | 343,494 | 248,528 | 196,282 | 191,551 | 104,296 |
| Operating Income | -87,606 | -109,154 | -131,220 | -173,413 | -104,296 |
| Interest Expense | 14,311 | 15,105 | 15,979 | 17,590 | 335 |
| Other Income | 15,005 | -38,165 | 5,128 | 107,052 | 1,367 |
| Pre-tax Income | -86,912 | -162,424 | -142,071 | -83,951 | -103,264 |
| Income Tax | 1,030 | 991 | -6,406 | 37 | 6 |
| Net Income Continuous | -87,942 | -163,415 | -135,665 | -83,988 | -103,270 |
| Net Income | $-87,942 | $-163,415 | $-135,665 | $-83,988 | $-103,270 |
| EPS Basic Total Ops | -1.85 | -4.00 | -4.01 | -2.77 | -4.09 |
| EPS Basic Continuous Ops | -1.85 | -4.00 | -4.01 | -2.77 | -4.09 |
| EPS Diluted Total Ops | -1.85 | -4.00 | -4.02 | -2.77 | -4.09 |
| EPS Diluted Continuous Ops | -1.85 | -4.00 | -3.99 | -2.77 | -4.09 |
| EPS Diluted Before Non-Recurring Items | -1.85 | -2.92 | -4.02 | -5.58 | -4.09 |
| EBITDA(a) | $-62,316 | $-97,208 | $-127,982 | $-172,818 | $-103,673 |